Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Frequency and risk factors of sleep disturbances in patients with prostate cancer assigned to local or loco-regional radiotherapy

Svenja Kopelke, Tobias Bartscht, Steven E. Schild, Soeren Tvilsted, Troels W. Kjaer, Dirk Rades*

*Korrespondierende/r Autor/-in für diese Arbeit

Abstract

Background/Aim: Many patients with prostate cancer receive definitive or adjuvant radiotherapy. This study aimed to identify the frequency of sleep disturbances and corresponding risk factors prior to radiation treatment. Patients and Methods: Data of 48 patients assigned to local or loco-regional irradiation for prostate cancer were retrospectively analyzed for pre-radiotherapy sleep disturbances. Fifteen characteristics were analyzed including age, performance status, comorbidity, history of previous malignancy, distress score, (emotional, physical or practical) problems, prostate-specific antigen, primary tumor stage, Gleason-score, upfront androgen deprivation therapy (ADT), treatment volume, brachytherapy, and COVID-19 pandemic. Results: Pre-radiotherapy sleep disturbances were reported by 20.8% of patients and significantly associated with distress scores ≥4 (p<0.0001) and ≥3 physical problems (p=0.0001). Trends were found for Karnofsky performance score ≤80 (p=0.095), Gleason score 7b-9 (p=0.079), and ADT (p=0.067). Conclusion: Pre-radiotherapy sleep disturbances were less common in prostate cancer patients than in other cancer patients. Risk factors were identified that can help identify patients requiring psychological support prior to radiotherapy.

OriginalspracheEnglisch
ZeitschriftAnticancer Research
Jahrgang41
Ausgabenummer10
Seiten (von - bis)5165-5169
Seitenumfang5
ISSN0250-7005
DOIs
PublikationsstatusVeröffentlicht - 10.2021

Fördermittel

As part of the project NorDigHealth, this study is funded by the European Regional Development Fund through the Interreg Deutschland-Danmark program.

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gesundheit und Wohlergehen
    SDG 3 – Gesundheit und Wohlergehen

Strategische Forschungsbereiche und Zentren

  • Zentren: Universitäres Cancer Center Schleswig-Holstein (UCCSH)
  • Profilbereich: Lübeck Integrated Oncology Network (LION)

Zitieren